InvitroLab, the biofactory recently inaugurated by Camposol in Chao (Virú), will make it possible to scale the company’s proprietary blueberry genetics program, integrating science, biotechnology and nurseries in a closed production model.
The opening of InvitroLab not only adds a new technological infrastructure to the Chao valley; it also consolidates Camposol’s strategy to build its own genetic platform for blueberries, capable of supporting the company’s growth with differentiated, high-performance plant material.
From the new facilities, the company aims to produce more than 5 million blueberry plantlets and other species, relying on integrated in vitro and ex vitro processes based on advanced biotechnology protocols. The goal is to reduce dependence on third parties, ensure quality and traceability of plant material, and respond more swiftly to international market trends.
A new phase for Camposol
“This milestone marks the beginning of a new phase in our journey towards a more sustainable, competitive and science-based agro-industry,” said Ricardo Naranjo Fernández, CEO of Camposol, presenting the facility.
The executive explained that having an in-house biofactory will allow them to “multiply our genetics with greater precision, speed and consistency,” resulting in better support for planting plans and greater technological autonomy in the face of changing conditions.
One of the core elements of the project is the industrial scaling of three new blueberry varieties developed through the company’s genetics program. These varieties are the result of more than ten years of research, agronomic field evaluations and detailed post-harvest analyses, in search of superior parameters in firmness, size, flavor, productivity and shelf-life in destination markets.
Autonomy and competitiveness
“Seeing these varieties born from our genetic program and now having the industrial capacity to multiply them is a tremendous source of pride for the entire organization,” said Naranjo Fernández, explicitly acknowledging the contribution of the Genetics, Biofactory and Nursery teams, as well as the technical and scientific support that has accompanied the project from the start.
Camposol’s strategy fits into a context of growing global competition in blueberries, where retailers and consumers demand fruit with consistent premium standards. In this scenario, biotechnology and proprietary genetics programs have become strategic tools to differentiate and guarantee a stable supply throughout the season.
“InvitroLab is the concrete expression of our spirit: transforming the field with science, technology and a vision for the future. With this new step, we reaffirm our commitment to working the land to improve people’s lives,” the CEO of Camposol concluded.
A model for fruit production
During the inauguration, the presence of industry companies, trade organizations and strategic partners highlighted the interest that initiatives like this generate in Latin American fruit production.
Beyond the numbers, InvitroLab is emerging as a case study on how to integrate innovation, genetics and large-scale production to meet the demands of a blueberry market that continues to raise the bar in terms of quality and sustainability.
Text and images source: diariofruticola.cl
